Agilux Laboratories
Worcester, MACRO providing integrated small and large molecule discovery and bioanalytical, drug metabolism and pharmacokinetic, and pharmacology services
Acquired by Charles River Laboratories in 2016
View CompanyLaboratory Services
Decades of research into the genetic basis of disease has driven a shift towards precision medicines that use a patient’s genomic, environmental and lifestyle parameters to guide the treatment and management of their disease.
This has heavily influenced drug discovery, diagnosis and treatment. It has required advances like the development of complex molecular analyses and identification of novel biomarkers. These advances, in turn, are driving the market for increasingly specialized outsourced laboratory services.
With deep expertise in laboratory services, Ampersand’s team has established impactful collaborations with portfolio companies working in this area. Adding value alongside our investments through market knowledge, strategic acumen, a large network, and decades of operational experience, Ampersand is able to offer a differentiating platform for growth.
Key Subsectors
- Diagnostic Testing
- Regulatory Testing
- Manufacturing Support
Laboratory Services Portfolio
Status
Explore the Full Ampersand Portfolio
AnaBios
San Diego, CAProcurement and logistics management of high-quality human tissue and cells for drug discovery and academic research
View Company
Bako Diagnostics
Alpharetta, GAPremier provider of diagnostic and therapeutic services focused on skin, soft tissue, and bone of the lower extremities
Acquired by Consonance Capital in 2016
View Company
ChanTest
Cleveland, OHProvider of ion channel testing services for drug safety and discovery
Acquired by Charles River Laboratories in 2014
View Company
Flagship Biosciences
Broomfield, COLeader in spatial biology and biomarker analysis for clinical research and drug development
View Company
GENEWIZ
South Plainfield, NJGlobal leader in R&D genomics services
Acquired by Brooks Automation in 2018
View Company
Genoptix
Carlsbad, CASpecialized laboratory services for hematology and oncology
Acquired by NeoGenomics in 2018
View Company
Interpace Biosciences
Parsippany, NJProvider of complex molecular analysis for the early diagnosis and the treatment of cancer
View Company
Meadowhawk Biolabs
Marlborough, MAPreclinical CRO advancing R&D for bioanalytical, pharmacokinetic, and pharmacology studies
View Company
Nexelis
Quebec, CanadaR&D solutions for the development of immunotherapeutics, including biologics, antiviral drugs, and cell and gene therapies
Acquired by Q2 Solutions in 2022
View Company
ProtaGene
Heilbronn, Germany,Leading global provider of biopharmaceutical, cell, and gene therapy analytical solutions
View Company
Resolian
Malvern, PAAnalytical services for the testing of raw materials, formulated products, packaging, and medical devices
View Company
Signature Genomics Laboratories
Spokane, WAPioneering laboratory credited with providing the first microarray-based cytogenetic diagnostics for intellectual disability and birth defects
Acquired by PerkinElmer in 2010
View Company
StageBio
Mount Jackson, VALeading international provider of preclinical and clinical histology, pathology, image analysis, and specimen archiving services
View Company
Viracor-IBT Laboratories
Lee’s Summit, MODiagnostic laboratory specializing in infectious diseases, immunology, and allergy testing for immunocompromised and critical patients
Acquired by Eurofins Scientific in 2014
View Company
